Niharika Tarimela
MSIS
Healthcare Analyst
San Diego, CA, US
Niharika is an analyst with the San Diego office of Milliman. She joined the firm in 2018, and works across different Milliman teams to support a wide range of projects and clients, including market checks, claims reporting, pharmacy, medical audits, Medicare Part D plans, self-insured employer groups, and third-party administrators.
Experience
Niharika’s primary areas of expertise are data warehousing, product development, data validation, results analysis and interpretation, on-demand custom report building, error troubleshooting, and recommending solutions for process improvements.
She is proficient in various technical skills like SQL, SSAS, SSIS, Power BI, and PowerShell.
Niharika’s experience includes:
- Data analysis and reporting
- Database management
- Data cleansing and validation
- Data visualization
- Performance guarantees
- Pharmacy Benefit Manager audits
- Pharmacy claims processing
- Product development and execution of Milliman products such as MyRxConsultant and Milliman Payment Integrity
- Process enhancements and performance optimization
- PBM Market Check
- Medicare Part D data validation
- Medicare Part D Employer Group Waiver Plans (EGWP)
Education
- MS, Information Science and Technology, Missouri University of Science and Technology, Rolla
- MBA, Campbellsville University, Louisville
Publications
Read their latest work
Article
Commercial drug trends: 2024 release
24 July 2024 - by Brian Anderson, Rebekah Bayram, Andrew Dressler, Marc Guieb, Niharika Tarimela, Jason Mui
Pharmacy benefits costs continue to rise year over year, driven by a variety of factors such as novel treatments, consumer demand, and federal legislation.
Article
Commercial Drug Trends: 2023 release
13 October 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb, Niharika Tarimela, Andrew Dressler
Average wholesale drug prices per member will increase 11% to 19% among commercial health plans from 2022 to 2024, according to our analysis of pharmaceutical spending trends.